Regulation of cyclooxygenase-2 pathway by HER2 receptor.
about
The Mediterranean diet: effects on proteins that mediate fatty acid metabolism in the colonSelective induction of cyclooxygenase-2 plays a role in lysophosphatidic acid regulated Fas ligand cell surface presentationExpression and transactivating functions of the bZIP transcription factor GADD153 in mammary epithelial cellsInflammation and breast cancer. Cyclooxygenase/prostaglandin signaling and breast cancermRNA profiling reveals determinants of trastuzumab efficiency in HER2-positive breast cancer15-Hydroxyprostaglandin dehydrogenase is down-regulated in colorectal cancerMicrosomal prostaglandin E2 synthase-1 is induced by conditional expression of RET/PTC in thyroid PCCL3 cells through the activation of the MEK-ERK pathway.Cyclo-oxygenase-2 (Cox-2) expression and resistance to platinum versus platinum/paclitaxel containing chemotherapy in advanced ovarian cancer.Chemoprevention of 7,12-dimethylbenz[a]anthracene (DMBA)-induced oral carcinogenesis in hamster cheek pouch by topical application of a dual inhibitor of epidermal growth factor receptor (EGFR) and ErbB2 tyrosine kinasesDistinct role of Kruppel-like factor 11 in the regulation of prostaglandin E2 biosynthesis.Biliary cancer growth factor pathways, cyclo-oxygenase-2 and potential therapeutic strategies.Increasing CD44+/CD24(-) tumor stem cells, and upregulation of COX-2 and HDAC6, as major functions of HER2 in breast tumorigenesisHER-2/neu represses the metastasis suppressor RECK via ERK and Sp transcription factors to promote cell invasion.The oncogene HER2: its signaling and transforming functions and its role in human cancer pathogenesisCytosolic phospholipase A2-α expression in breast cancer is associated with EGFR expression and correlates with an adverse prognosis in luminal tumours.Celecoxib: a specific COX-2 inhibitor with anticancer properties.Integrin alpha5/beta1 mediates fibronectin-dependent epithelial cell proliferation through epidermal growth factor receptor activationSelective cyclooxygenase-2 inhibition: a target in cancer prevention and treatment.Erbb2 regulates inflammation and proliferation in the skin after ultraviolet irradiationExpression of COX-2 and HER-2 in colorectal cancer and their correlation.Overexpression of cyclo-oxygenase-2 is an independent predictor of unfavourable outcome in node-negative breast cancer, but is not associated with protein kinase B (Akt) and mitogen-activated protein kinase (ERK1/2, p38) activation or with Her-2/neuReview article: the potential of combinational regimen with non-steroidal anti-inflammatory drugs in the chemoprevention of colorectal cancer.Antimitogenic effects of HDL and APOE mediated by Cox-2-dependent IP activation.Correlation of COX-2 and Ep-CAM overexpression in human invasive breast cancer and its impact on survival.COX-2 expression is associated with an aggressive phenotype in ductal carcinoma in situ.Phosphorylated epidermal growth factor receptor and cyclooxygenase-2 expression in localized non-small cell lung cancerEffects of ectopic HER-2/neu gene expression on the COX-2/PGE2/P450arom signaling pathway in endometrial carcinoma cells: HER-2/neu gene expression in endometrial carcinoma cellsEGFR and HER2 signaling in breast cancer brain metastasis.Cox-2 inactivates Smad signaling and enhances EMT stimulated by TGF-beta through a PGE2-dependent mechanisms.The ERBB3 receptor in cancer and cancer gene therapyRole of ErbB family receptor tyrosine kinases in intrahepatic cholangiocarcinomaThe inhibition of early stages of HER-2/neu-mediated mammary carcinogenesis by dietary n-3 PUFAs.Targeting receptor tyrosine kinases for chemoprevention by green tea catechin, EGCGExpression of cyclooxygenase-2 in human breast cancer: relationship with HER-2/neu and other clinicopathological prognostic factors.Role of Cyclooxygenase 2 (COX-2) in Prognosis of Breast Cancer.Colorectal cancer in review: the role of the EGFR pathway.Biliary tract carcinoma: clinical perspectives on molecular targeting strategies for therapeutic options.Cyclooxygenase-2 is overexpressed in HER-2/neu-positive breast cancer: evidence for involvement of AP-1 and PEA3.Nitric oxide upregulates the cyclooxygenase-2 expression through the cAMP-response element in its promoter in several cancer cell lines.COX-2 expression in DCIS: correlation with VEGF, HER-2/neu, prognostic molecular markers and clinicopathological features.
P2860
Q26992027-B0D50475-273F-4EC8-B4B4-91A33312E2EFQ28194138-9817753D-672F-46A7-94CA-B350F3739F7EQ28206850-F1DEA2A7-9EC5-4196-9A33-964711624890Q28218639-C173A070-443F-41C1-8B5C-9A809471722BQ28543647-CA2A2ACB-FB36-46F6-9E04-395D2A77E5D3Q28592082-DCF368F5-30A3-411C-94A1-A66C7ADBF2E5Q33193878-DD50D494-C8EB-47CA-AEDB-CC3D305F9DBFQ33249461-2325A50A-2DB0-48EE-A347-F9D5DC8F6FC6Q33302631-93EC62F3-8F8A-40B1-8F0D-6FA2FE3A61FFQ33799761-1B805517-C173-4C31-BCDF-A87CAE13A9E4Q34253944-C8FABFA4-CA04-45E5-B1CA-1884F89D2ABDQ34338501-7FD03914-586B-4D61-B479-207F70ED9BD3Q34479560-DFAF0514-1040-4B9F-BE4E-7C1951B89EBCQ34493341-956A4716-8E30-426C-8ED9-66619759E7C7Q34543740-8058824C-39EC-455A-AC3F-8ADA19CF93F6Q34608635-C06D5DCF-BABF-4DE4-A76F-1992240A2D6DQ34735845-1984D7C6-4294-45B3-ABC2-8A0D3A5E2659Q35043366-A7414FA3-0790-4D88-AC9C-D3EE6B177582Q35607262-981A3439-F2AD-40DD-BC43-41571CB695D6Q35651481-87E410A6-B08B-440A-9B95-B0DA3D980E2EQ35770111-25260B50-E914-4953-9940-2447C8B2E665Q36041152-78C85232-A3FA-426C-99CC-24862A69F38DQ36056768-EB723CB8-E8EF-46D1-AF9D-F9C21F67A347Q36649103-55EF17BD-81D1-46FE-8530-1816520CF6B3Q36694470-09080367-47F8-4E0B-BBAD-B504C770B1DFQ36717778-228431E3-E89D-44C1-B327-66A4B7E4C35EQ36722388-A5F081D1-B587-4029-88BD-DE4E1C2FA054Q36733618-055926D9-5D1E-41E2-A703-7327CACE0678Q36959011-985B1BF2-9EFF-4E44-9EED-CCE7495D5D0DQ37135372-8852DE62-4B68-492A-B9AB-1C1A83A08F73Q37351498-15379B1E-2C14-41A2-865B-2F3CA483D1B1Q37372902-50EAD059-87C9-432A-9F27-AF647E1829B2Q37424846-1BF64A92-564C-429D-8748-312D9EE1CF60Q37446995-AA81F730-54E1-4422-ABA4-D9C7787EC0FDQ37660357-F5A9995E-2B66-48F7-B55A-8FFDCD771773Q37679938-592A65AB-5427-4408-A0AF-164FD08F2365Q38017118-513419D4-4BB3-4D77-9EAC-EFA7C22D6F01Q38291062-611EE1BB-6456-4418-A291-24E77D4F7C60Q38323790-FAC05350-8261-4420-8DAD-2FA3CB51EBB8Q38443121-657C3591-ED5B-4342-9691-A9EF4636B232
P2860
Regulation of cyclooxygenase-2 pathway by HER2 receptor.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
Regulation of cyclooxygenase-2 pathway by HER2 receptor.
@en
Regulation of cyclooxygenase-2 pathway by HER2 receptor.
@nl
type
label
Regulation of cyclooxygenase-2 pathway by HER2 receptor.
@en
Regulation of cyclooxygenase-2 pathway by HER2 receptor.
@nl
prefLabel
Regulation of cyclooxygenase-2 pathway by HER2 receptor.
@en
Regulation of cyclooxygenase-2 pathway by HER2 receptor.
@nl
P2093
P356
P1433
P1476
Regulation of cyclooxygenase-2 pathway by HER2 receptor.
@en
P2093
P2888
P304
P356
10.1038/SJ.ONC.1202307
P407
P577
1999-01-01T00:00:00Z
P5875
P6179
1028224512